Characterization of histamine H-1 receptors on human peripheral lung

Biochemical Pharmacology
T B CasaleM Kaliner

Abstract

Histamine H-1 receptors in human peripheral lung were characterized by radioligand and biochemical assays employing binding of the H-1 receptor antagonist [3H]pyrilamine to plasma membrane preparations. Simultaneous computerized analyses of the data from fourteen separate equilibrium-binding assays indicated the presence of three distinct classes of binding sites with Kd values of 81 +/- 35 pM, 7 +/- 3 microM, and 320 +/- 167 microM and binding capacities of 23 +/- 3 pmoles, 10 +/- 5 nmoles, and 297 +/- 119 nmoles/mg protein respectively. Dissociation kinetics of [3H]pyrilamine binding also supported the presence of three binding sites or states. Further, competition binding curves for histamine receptor agonists and antagonists also indicated the presence of multiple binding sites for the H-1 receptor. The effect of exogenous stimulation of histamine H-1 receptors on human cyclic nucleotides was also examined. Both histamine and the H-1 agonist 2-methyl histamine caused dose-related increases in the cyclic guanosine monophosphate (GMP) content of human lung. The effects of 2-methyl histamine were selective for cyclic GMP. The histamine-induced increase in cyclic GMP peaked within 1.0 min and was effectively prevented by the H-...Continue Reading

References

Sep 1, 1976·The Journal of Investigative Dermatology·A P Kaplan, M A Beaven
Sep 1, 1978·The American Journal of Physiology·K M BaldwinR E Lewis
Oct 1, 1979·The Journal of Allergy and Clinical Immunology·L SteelM Kaliner
Jun 1, 1978·The Journal of Clinical Investigation·J M Drazen, M W Schneider
Apr 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·A R Johnson, E G Erdös
Sep 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·A G Gilman
Feb 1, 1968·The Journal of Experimental Medicine·C G Cochrane, H J Müller-Eberhard
Feb 1, 1973·The Journal of Clinical Investigation·B M JaffeC W Parker
Oct 1, 1971·Circulation Research·G G PietraA P Fishman
Jul 1, 1971·Journal of Applied Physiology·H Sellick, J G Widdicombe
Apr 1, 1980·Environmental Health Perspectives·S I Wasserman
May 22, 1980·Biochimica Et Biophysica Acta·J C Foreman, L M Lichtenstein
Aug 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·F ErjavecP Holzer
Jul 17, 1981·European Journal of Pharmacology·T C Theoharides, W W Douglas
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Jul 1, 1982·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·T AhmedA Wanner
Dec 1, 1981·Journal of Clinical Pathology·B FoxA Guz
Jun 1, 1980·Clinical Science·N M EiserA Guz
Oct 1, 1980·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·N ChandB M Altura
Dec 31, 1910·The Journal of Physiology·H H Dale, P P Laidlaw

❮ Previous
Next ❯

Citations

Mar 1, 1988·Biochemical Pharmacology·J P Joad, T B Casale
Jul 23, 1987·European Journal of Pharmacology·A G Driver, S J Mustafa
Jul 17, 1990·European Journal of Pharmacology·G O PesceD Rodbard
May 2, 1991·European Journal of Pharmacology·T A Bökesoy, H O Onaran
Jun 1, 1995·Pharmacology & Therapeutics·R LeursH Timmerman
Feb 13, 1992·European Journal of Pharmacology·R LeursH Timmerman
Feb 17, 1999·The Journal of Experimental Medicine·Y Banu, T Watanabe
Feb 6, 2004·Pediatric Emergency Care·Russ Horowitz, Sally Reynolds
Dec 1, 1990·American Journal of Respiratory Cell and Molecular Biology·M CluzelL M Lichtenstein
Apr 1, 1989·The Journal of Allergy and Clinical Immunology·T B Casale
Mar 1, 1988·Journal of Cellular Physiology·M Mitsuhashi, D G Payan
Jun 1, 1989·Journal of Cellular Biochemistry·M Mitsuchashi, D G Payan
Oct 1, 1987·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·T Hallberg, M Dohlsten
Oct 18, 2001·Pulmonary Pharmacology & Therapeutics·P J Barnes
Aug 1, 1987·Biochemical Pharmacology·T B Casale, J E Hart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.